![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Found 1251 studies with search of: | "Cisplatin" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Terminated |
Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC
|
||||
2 | Recruiting |
Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC
|
||||
3 | Not yet recruiting |
Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)
|
||||
4 | Recruiting |
Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer
|
||||
5 | Active, not recruiting |
A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC
|
||||
6 | Recruiting |
Study of Concurrent Pemetrexed, Cisplatin and Radiotherapy in Local Advanced Non-Small Cell Lung Cancer
|
||||
7 | Recruiting |
Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer
|
||||
8 | Active, not recruiting |
Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract
|
||||
9 | Completed |
Study of Cisplatin/Vinorelbine +/- Cetuximab as First-Line Treatment of Advanced Non Small Cell Lung Cancer(FLEX)
|
||||
10 | Completed |
Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer
|
||||
11 | Recruiting |
Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC)
|
||||
12 | Active, not recruiting |
Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC)
|
||||
13 | Completed |
Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st-Line Extensive Disease Small Cell Lung Cancer
|
||||
14 | Recruiting |
A Phase III Randomized, Double-Blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients With Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC)
|
||||
15 | Recruiting |
Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer
|
||||
16 | Recruiting |
Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement
|
||||
17 | Recruiting |
Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES)
|
||||
18 | Recruiting |
Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
|
||||
19 | Recruiting |
Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer
|
||||
20 | Active, not recruiting |
OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer
|
![]() |
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
![]() |